Signaling Pathways
-
A8488 NVP-BGT226Target: PI3K|mTORSummary: PI3K/mTOR inhibitor,selective and novel
-
A8496 PaliperidoneTarget: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 ReceptorsSummary: Dopamine receptor antagonist
-
A8499 PF-04691502Target: Akt|PI3K|mTORSummary: PI3K/mTOR (FRAP) inhibitor
-
A8501 PHA-848125Target: Cyclin-Dependent KinasesSummary: CDK inhibitor,potent and ATP-competitive
-
A8503 PiroxicamTarget: COX|Prostaglandin synthesisSummary: Prostaglandin synthesis/Coxinhibitor
-
A8504 Pitavastatin Calcium1 CitationTarget: HMG-CoA ReductasesSummary: Enzyme HMGCR inhibitor
-
A8506 Potassium CanrenoateTarget: Aldosterone receptorSummary: Aldosterone antagonist
-
A8510 Ranolazine1 CitationTarget: calcium uptakeSummary: Anti-ischemic
-
A8513 RiluzoleTarget: Voltage-gated Sodium (NaV) Channels|glutamate releaseSummary: Sodium channel protein inhibitor
-
A8521 SilodosinSummary: α1-adrenoceptor antagonist